Cam Gallagher is of Ocuphire Pharma, Inc.. Currently has a direct ownership of 77,047 shares of OCUP, which is worth approximately $75,506. The most recent transaction as insider was on Jun 11, 2024, when has been sold 41,143 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 77K
0% 3M change
114.59% 12M change
Total Value Held $75,506

Cam Gallagher Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 11 2024
BUY
Grant, award, or other acquisition
-
41,143 Added 34.81%
77,047 Common Stock
Jun 06 2023
BUY
Grant, award, or other acquisition
-
10,976 Added 23.41%
35,904 Common Stock
Jan 04 2023
BUY
Exercise of in-the-money or at-the-money derivatives securities
-
1,574 Added 5.94%
24,928 Common Stock
Nov 19 2020
BUY
Open market or private purchase
-
8,865 Added 27.51%
23,354 Common Stock
Nov 05 2020
BUY
Grant, award, or other acquisition
-
14,489 Added 50.0%
14,489 Common Stock

Also insider at

ZNTL
Zentalis Pharmaceuticals, Inc. Healthcare
CG

Cam Gallagher

New York, NY

Track Institutional and Insider Activities on OCUP

Follow Ocuphire Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUP shares.

Notify only if

Insider Trading

Get notified when an Ocuphire Pharma, Inc. insider buys or sells OCUP shares.

Notify only if

News

Receive news related to Ocuphire Pharma, Inc.

Track Activities on OCUP